Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Prostate Cancer

  Free Subscription


Articles published in Oncol Rep

Retrieve available abstracts of 57 articles:
HTML format
Text format



Single Articles


    November 2017
  1. WA Q, Li L, Lin H, Peng X, et al
    Downregulation of miR19a3p promotes invasion, migration and bone metastasis via activating TGFbeta signaling in prostate cancer.
    Oncol Rep. 2017 Nov 13. doi: 10.3892/or.2017.6096.
    PubMed     Text format     Abstract available


  2. KUBO M, Satoh T, Ishiyama H, Tabata KI, et al
    Enhanced activated T cell subsets in prostate cancer patients receiving iodine-125 low-dose-rate prostate brachytherapy.
    Oncol Rep. 2017 Nov 13. doi: 10.3892/or.2017.6095.
    PubMed     Text format     Abstract available


  3. ZOU P, Yang Y, Xu X, Liu B, et al
    Silencing of vacuolar ATPase c subunit ATP6V0C inhibits the invasion of prostate cancer cells through a LASS2/TMSG1-independent manner.
    Oncol Rep. 2017 Nov 10. doi: 10.3892/or.2017.6092.
    PubMed     Text format     Abstract available


  4. SZYSZKA M, Tyczewska M, Milecka P, Jopek K, et al
    Effects of leptin on leptin receptor isoform expression and proliferative activity in human normal prostate and prostate cancer cell lines.
    Oncol Rep. 2017 Nov 1. doi: 10.3892/or.2017.6066.
    PubMed     Text format     Abstract available


    October 2017
  5. KOU B, Liu W, Zhao W, Duan P, et al
    Thymoquinone inhibits epithelial-mesenchymal transition in prostate cancer cells by negatively regulating the TGF-beta/Smad2/3 signaling pathway.
    Oncol Rep. 2017 Oct 2. doi: 10.3892/or.2017.6012.
    PubMed     Text format     Abstract available


    September 2017
  6. NOWACKA-ZAWISZA M, Wisnik E
    DNA methylation and histone modifications as epigenetic regulation in prostate cancer (Review).
    Oncol Rep. 2017 Sep 20. doi: 10.3892/or.2017.5972.
    PubMed     Text format     Abstract available


  7. ZHOU Y, Gu P, Li J, Li F, et al
    Suppression of STIM1 inhibits the migration and invasion of human prostate cancer cells and is associated with PI3K/Akt signaling inactivation.
    Oncol Rep. 2017 Sep 18. doi: 10.3892/or.2017.5961.
    PubMed     Text format     Abstract available


  8. LING Z, Liu D, Zhang G, Liang Q, et al
    miR-361-5p modulates metabolism and autophagy via the Sp1-mediated regulation of PKM2 in prostate cancer.
    Oncol Rep. 2017;38:1621-1628.
    PubMed     Text format     Abstract available


    August 2017
  9. KHURANA N, Kim H, Chandra PK, Talwar S, et al
    Multimodal actions of the phytochemical sulforaphane suppress both AR and AR-V7 in 22Rv1 cells: Advocating a potent pharmaceutical combination against castration-resistant prostate cancer.
    Oncol Rep. 2017 Aug 30. doi: 10.3892/or.2017.5932.
    PubMed     Text format     Abstract available


    July 2017
  10. GAO C, Zhou Y, Jiang Z, Zhao Y, et al
    Cytotoxic and chemosensitization effects of Scutellarin from traditional Chinese herb Scutellaria altissima L. in human prostate cancer cells.
    Oncol Rep. 2017 Jul 24. doi: 10.3892/or.2017.5850.
    PubMed     Text format     Abstract available


  11. ZHOU Y, Ji Z, Yan W, Zhou Z, et al
    The biological functions and mechanism of miR212 in prostate cancer proliferation, migration and invasion via targeting Engrailed-2.
    Oncol Rep. 2017 Jul 12. doi: 10.3892/or.2017.5805.
    PubMed     Text format     Abstract available


    June 2017
  12. ZHOU Y, Ji Z, Yan W, Zhou Z, et al
    Tetramethylpyrazine inhibits prostate cancer progression by downregulation of forkhead box M1.
    Oncol Rep. 2017 Jun 29. doi: 10.3892/or.2017.5768.
    PubMed     Text format     Abstract available


  13. XUAN Q, Zhong X, Li W, Mo Z, et al
    CtBP2 is associated with angiogenesis and regulates the apoptosis of prostate cancer cells.
    Oncol Rep. 2017 Jun 28. doi: 10.3892/or.2017.5763.
    PubMed     Text format     Abstract available


    May 2017
  14. HATA S, Nomura T, Iwasaki K, Sato R, et al
    Hypoxia-induced angiopoietin-like protein 4 as a clinical biomarker and treatment target for human prostate cancer.
    Oncol Rep. 2017 May 24. doi: 10.3892/or.2017.5669.
    PubMed     Text format     Abstract available


  15. LIU L, Lou N, Li X, Xu G, et al
    Calpain and AR-V7: Two potential therapeutic targets to overcome acquired docetaxel resistance in castration-resistant prostate cancer cells.
    Oncol Rep. 2017 May 4. doi: 10.3892/or.2017.5623.
    PubMed     Text format     Abstract available


  16. BAI S, Chen T, Yu X, Luo M, et al
    The specific killing effect of matrine on castration-resistant prostate cancer cells by targeting the Akt/FoxO3a signaling pathway.
    Oncol Rep. 2017;37:2819-2828.
    PubMed     Text format     Abstract available


    April 2017
  17. YIN B, Liu Z, Wang Y, Wang X, et al
    RON and c-Met facilitate metastasis through the ERK signaling pathway in prostate cancer cells.
    Oncol Rep. 2017 Apr 19. doi: 10.3892/or.2017.5585.
    PubMed     Text format     Abstract available


    March 2017
  18. ZHAO Y, Yan M, Yun Y, Zhang J, et al
    MicroRNA-455-3p functions as a tumor suppressor by targeting eIF4E in prostate cancer.
    Oncol Rep. 2017 Mar 13. doi: 10.3892/or.2017.5502.
    PubMed     Text format     Abstract available


  19. BAI Y, Xiao Y, Dai Y, Chen X, et al
    Stanniocalcin 1 promotes cell proliferation via cyclin E1/cyclindependent kinase 2 in human prostate carcinoma.
    Oncol Rep. 2017 Mar 13. doi: 10.3892/or.2017.5501.
    PubMed     Text format     Abstract available


  20. TAO T, Chen M, Jiang R, Guan H, et al
    Involvement of EZH2 in aerobic glycolysis of prostate cancer through miR-181b/HK2 axis.
    Oncol Rep. 2017;37:1430-1436.
    PubMed     Text format     Abstract available


  21. ZHANG H, Du X, Sun TT, Wang CL, et al
    Lectin PCL inhibits the Warburg effect of PC3 cells by combining with EGFR and inhibiting HK2.
    Oncol Rep. 2017;37:1765-1771.
    PubMed     Text format     Abstract available


    February 2017
  22. YU H, Sun SQ, Gu XB, Wang W, et al
    Atorvastatin prolongs the lifespan of radiationinduced reactive oxygen species in PC-3 prostate cancer cells to enhance the cell killing effect.
    Oncol Rep. 2017 Feb 14. doi: 10.3892/or.2017.5447.
    PubMed     Text format     Abstract available


  23. KONG Q, Chen XS, Tian T, Xia XY, et al
    MicroRNA-194 suppresses prostate cancer migration and invasion by downregulating human nuclear distribution protein.
    Oncol Rep. 2017;37:803-812.
    PubMed     Text format     Abstract available


    January 2017
  24. LIU Y, Qin Z, Yang K, Liu R, et al
    Cripto-1 promotes epithelial-mesenchymal transition in prostate cancer via Wnt/beta-catenin signaling.
    Oncol Rep. 2017 Jan 17. doi: 10.3892/or.2017.5378.
    PubMed     Text format     Abstract available


  25. HE Y, Huang H, Farischon C, Li D, et al
    Combined effects of atorvastatin and aspirin on growth and apoptosis in human prostate cancer cells.
    Oncol Rep. 2017 Jan 4. doi: 10.3892/or.2017.5353.
    PubMed     Text format     Abstract available


  26. LIU B, Gu X, Huang T, Luan Y, et al
    Identification of TMPRSS2-ERG mechanisms in prostate cancer invasiveness: Involvement of MMP-9 and plexin B1.
    Oncol Rep. 2017;37:201-208.
    PubMed     Text format     Abstract available


  27. SUN W, Guo L, Shao G, Liu X, et al
    Suppression of LASP-1 attenuates the carcinogenesis of prostatic cancer cell lines: Key role of the NF-kappaB pathway.
    Oncol Rep. 2017;37:341-347.
    PubMed     Text format     Abstract available


    December 2016
  28. YIN H, Sheng Z, Zhang X, Du Y, et al
    Overexpression of SOX18 promotes prostate cancer progression via the regulation of TCF1, c-Myc, cyclin D1 and MMP-7.
    Oncol Rep. 2016 Dec 2. doi: 10.3892/or.2016.5288.
    PubMed     Text format     Abstract available


    November 2016
  29. LI S, Wang C, Yu X, Wu H, et al
    miR-3619-5p inhibits prostate cancer cell growth by activating CDKN1A expression.
    Oncol Rep. 2016 Nov 16. doi: 10.3892/or.2016.5250.
    PubMed     Text format     Abstract available


  30. JANG IS, Park JW, Jo EB, Cho CK, et al
    Growth inhibitory and apoptosis-inducing effects of allergen-free Rhus verniciflua Stokes extract on A549 human lung cancer cells.
    Oncol Rep. 2016;36:3037-3043.
    PubMed     Text format     Abstract available


  31. OHNISHI Y, Yasui H, Kakudo K, Nozaki M, et al
    Lapatinib-resistant cancer cells possessing epithelial cancer stem cell properties develop sensitivity during sphere formation by activation of the ErbB/AKT/cyclin D2 pathway.
    Oncol Rep. 2016;36:3058-3064.
    PubMed     Text format     Abstract available


    October 2016
  32. LAI X, Guo Y, Guo Z, Liu R, et al
    Downregulation of microRNA574 in cancer stem cells causes recurrence of prostate cancer via targeting REL.
    Oncol Rep. 2016 Oct 24. doi: 10.3892/or.2016.5196.
    PubMed     Text format     Abstract available


  33. XU L, Wang Z, He SY, Zhang SF, et al
    Bax-interacting factor-1 inhibits cell proliferation and promotes apoptosis in prostate cancer cells.
    Oncol Rep. 2016 Oct 14. doi: 10.3892/or.2016.5172.
    PubMed     Text format     Abstract available


  34. ZHANG W, Liu J, Qiu J, Fu X, et al
    MicroRNA-382 inhibits prostate cancer cell proliferation and metastasis through targeting COUP-TFII.
    Oncol Rep. 2016 Oct 3. doi: 10.3892/or.2016.5141.
    PubMed     Text format     Abstract available


    August 2016
  35. CHEN Y, Zhao J, Luo Y, Wang Y, et al
    Downregulated expression of miRNA-149 promotes apoptosis in side population cells sorted from the TSU prostate cancer cell line.
    Oncol Rep. 2016 Aug 25. doi: 10.3892/or.2016.5047.
    PubMed     Text format     Abstract available


  36. ZHANG X, Wang L, Wang Y, Shi S, et al
    Inhibition of FOXQ1 induces apoptosis and suppresses proliferation in prostate cancer cells by controlling BCL11A/MDM2 expression.
    Oncol Rep. 2016 Aug 11. doi: 10.3892/or.2016.5018.
    PubMed     Text format     Abstract available


  37. FIALOVA B, Luzna P, Gursky J, Langova K, et al
    Epigenetic modulation of AR gene expression in prostate cancer DU145 cells with the combination of sodium butyrate and 5'-Aza-2'-deoxycytidine.
    Oncol Rep. 2016 Aug 3. doi: 10.3892/or.2016.5000.
    PubMed     Text format     Abstract available


  38. HUANG S, Tang Y, Peng X, Cai X, et al
    Acidic extracellular pH promotes prostate cancer bone metastasis by enhancing PC-3 stem cell characteristics, cell invasiveness and VEGF-induced vasculogenesis of BM-EPCs.
    Oncol Rep. 2016 Aug 2. doi: 10.3892/or.2016.4997.
    PubMed     Text format     Abstract available


    July 2016
  39. TIAN H, Zhou Y, Yang G, Geng Y, et al
    Sulforaphane-cysteine suppresses invasion via downregulation of galectin-1 in human prostate cancer DU145 and PC3 cells.
    Oncol Rep. 2016 Jul 15. doi: 10.3892/or.2016.4942.
    PubMed     Text format     Abstract available


  40. PING H, Yang F, Wang M, Niu Y, et al
    IKK inhibitor suppresses epithelial-mesenchymal transition and induces cell death in prostate cancer.
    Oncol Rep. 2016 Jul 7. doi: 10.3892/or.2016.4915.
    PubMed     Text format     Abstract available


    June 2016
  41. WANG D, Zhu L, Liao M, Zeng T, et al
    MYO6 knockdown inhibits the growth and induces the apoptosis of prostate cancer cells by decreasing the phosphorylation of ERK1/2 and PRAS40.
    Oncol Rep. 2016 Jun 29. doi: 10.3892/or.2016.4910.
    PubMed     Text format     Abstract available


  42. KIM TD, Shin S, Janknecht R
    ETS transcription factor ERG cooperates with histone demethylase KDM4A.
    Oncol Rep. 2016;35:3679-88.
    PubMed     Text format     Abstract available


    May 2016
  43. GRAVINA GL, Marampon F, Sanita P, Mancini A, et al
    Increased expression and activity of p75NTR are crucial events in azacitidine-induced cell death in prostate cancer.
    Oncol Rep. 2016 May 23. doi: 10.3892/or.2016.4832.
    PubMed     Text format     Abstract available


  44. YANG Y, Lu Y, Wang L, Mizokami A, et al
    Skp2 is associated with paclitaxel resistance in prostate cancer cells.
    Oncol Rep. 2016 May 13. doi: 10.3892/or.2016.4809.
    PubMed     Text format     Abstract available


  45. XU S, Yi XM, Tang CP, Ge JP, et al
    Long non-coding RNA ATB promotes growth and epithelial-mesenchymal transition and predicts poor prognosis in human prostate carcinoma.
    Oncol Rep. 2016 May 9. doi: 10.3892/or.2016.4791.
    PubMed     Text format     Abstract available


  46. ZHANG X, Tao T, Liu C, Guan H, et al
    Downregulation of miR-195 promotes prostate cancer progression by targeting HMGA1.
    Oncol Rep. 2016 May 9. doi: 10.3892/or.2016.4797.
    PubMed     Text format     Abstract available


    April 2016
  47. LI M, Wang YX, Luo Y, Zhao J, et al
    Hypoxia inducible factor-1alpha-dependent epithelial to mesenchymal transition under hypoxic conditions in prostate cancer cells.
    Oncol Rep. 2016 Apr 25. doi: 10.3892/or.2016.4766.
    PubMed     Text format     Abstract available


    March 2016
  48. LI F, Gu C, Tian F, Jia Z, et al
    miR-218 impedes IL-6-induced prostate cancer cell proliferation and invasion via suppression of LGR4 expression.
    Oncol Rep. 2016 Mar 8. doi: 10.3892/or.2016.4663.
    PubMed     Text format     Abstract available


  49. KOU B, Liu W, He W, Zhang Y, et al
    Tetrandrine suppresses metastatic phenotype of prostate cancer cells by regulating Akt/mTOR/MMP-9 signaling pathway.
    Oncol Rep. 2016 Mar 3. doi: 10.3892/or.2016.4649.
    PubMed     Text format     Abstract available


    February 2016
  50. WANG X, Niu Z, Jia Y, Cui M, et al
    Ubenimex inhibits cell proliferation, migration and invasion by inhibiting the expression of APN and inducing autophagic cell death in prostate cancer cells.
    Oncol Rep. 2016 Feb 3. doi: 10.3892/or.2016.4611.
    PubMed     Text format     Abstract available


  51. TANG J, Xiao L, Cui R, Li D, et al
    CX3CL1 increases invasiveness and metastasis by promoting epithelial-to-mesenchymal transition through the TACE/TGF-alpha/EGFR pathway in hypoxic androgenindependent prostate cancer cells.
    Oncol Rep. 2016;35:1153-1162.
    PubMed     Text format     Abstract available


  52. HUANG K, Tang Y, He L, Dai Y, et al
    MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway.
    Oncol Rep. 2016;35:887-895.
    PubMed     Text format     Abstract available


    January 2016
  53. YANG K, Shen J, Chen SW, Qin J, et al
    Upregulation of PAWR by small activating RNAs induces cell apoptosis in human prostate cancer cells.
    Oncol Rep. 2016 Jan 21. doi: 10.3892/or.2016.4582.
    PubMed     Text format     Abstract available


  54. KIM YR, Kang TW, To PK, Xuan Nguyen NT, et al
    HOXB13-mediated suppression of p21WAF1/CIP1 regulates JNK/c-Jun signaling in prostate cancer cells.
    Oncol Rep. 2016 Jan 15. doi: 10.3892/or.2016.4563.
    PubMed     Text format     Abstract available


    December 2015
  55. KANG M, Ho JN, Kook HR, Lee S, et al
    Theracurmin(R) efficiently inhibits the growth of human prostate and bladder cancer cells via induction of apoptotic cell death and cell cycle arrest.
    Oncol Rep. 2015 Dec 29. doi: 10.3892/or.2015.4537.
    PubMed     Text format     Abstract available


  56. YANG F, Jiang X, Song L, Wang H, et al
    Quercetin inhibits angiogenesis through thrombospondin-1 upregulation to antagonize human prostate cancer PC-3 cell growth in vitro and in vivo.
    Oncol Rep. 2015 Dec 9. doi: 10.3892/or.2015.4481.
    PubMed     Text format     Abstract available


    November 2015
  57. WANG L, Dong J, Wei M, Wen W, et al
    Selective and augmented beta-glucuronidase expression combined with DOX-GA3 application elicits the potent suppression of prostate cancer.
    Oncol Rep. 2015 Nov 26. doi: 10.3892/or.2015.4454.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: